Orexigen: Anti-Obesity Drug Attempting to Enter Multiple Markets
Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.
orexigen therapeutics
Compulsive Eating Similar to Drug Addiction, Researchers Say
A new study from the Scripps Research Institute has shown that the molecular mechanism that causes drug addiction is the same mechanism that drives people to compulsively eat.
Implantable Weight-Loss Device Receives CE Mark Approval
GI Dynamics has received European CE mark approval to commercialize a non-surgical device for the management of obesity and Type 2 diabetes.
Three Companies Race for Obesity Drug Approval
The race for an anti-obesity drug intensified Wednesday with the latest mid-stage trial data from Orexigen Therapeutics.